Efemoral Medical announced the presentation of long-term results from the initial 20 patients enrolled across four sites in ...

A case study on intravascular lithotripsy for the treatment of calcified carotid disease to demonstrate technical feasibility ...

The major thrust of current diagnostic and therapeutic strategies for coronary artery disease has overwhelmingly focused on late-stage atherosclerosis—ie, obstructive coronary artery disease—and its ...

A new study published in the journal of PLOS One showed that a decreased risk of peripheral artery disease (PAD) was linked to higher dietary vitamin E intake. Peripheral arterial disease is caused by ...

Candesartan treatment tended to improve the prognostic benefits after femoral artery stent implantation, suggesting that an antiproliferative effect after stenting may need higher doses than an ...

Semaglutide associated with increased walking distance in patients with symptomatic peripheral artery disease and type 2 diabetes. (HealthDay News) — For patients with symptomatic peripheral ...

Treatment with semaglutide improved maximum walking distance in patients with type 2 diabetes (T2D) and symptomatic peripheral artery disease (PAD), according to results from the STRIDE trial ...

ELEVATED remnant cholesterol (RC) exerts a stronger independent causal effect on peripheral artery disease (PAD) than LDL cholesterol (LDL-C), with LDL-C’s impact largely dependent on coexisting RC ...

NEW BLOOMFIELD — A vascular surgeon at SSM Health St. Mary's Hospital will hold two free discussions about peripheral arterial disease, which affects hundreds of millions of people worldwide.

Before his retirement, he was diagnosed with Peripheral Arterial Occlusive Disease in his right lower limb.